Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
The following is a summary of the NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript:
以下是NeueHealth, Inc.(NEUE)2024年第一季度财报电话会议记录摘要:
Financial Performance:
财务业绩:
NeueHealth reported a consolidated Q1 revenue of $245.1 million, slightly below expectations due to lower NeueCare volume and ACO business development.
The company delivered a gross margin of $48.2 million and a quarterly adjusted EBITDA of $2.5 million.
NeueCare segment revenue was $73.6 million with an operating income of $9.8 million.
The NeueSolution segment posted revenue of $173.9 million and an operating loss of $2.9 million.
NeueHealth报告称,由于NeueCare销量下降和ACO业务发展,第一季度合并收入为2.451亿美元,略低于预期。
该公司的毛利率为4,820万美元,季度调整后的息税折旧摊销前利润为250万美元。
NeueCare板块收入为7,360万美元,营业收入为980万美元。
NeueSolution板块公布的收入为1.739亿美元,营业亏损为290万美元。
Business Progress:
业务进展:
The NeueCare segment has expanded in Central Florida, adding 41,000 more consumers with plans for further expansions in 2024 and beyond.
NeueHealth served a total of 469,000 consumers across the NeueCare and NeueSolution segments in Q1 2024.
Growth in partnerships within the NeueSolution segment marks it as a key driver for the future.
The company serves approximately 40% of the 745,000 ACA marketplace consumers in the Miami-Dade market, receiving high customer satisfaction scores.
The company aims to serve between 475,000 and 500,000 consumers across both segments by the end of 2024, focusing on a value-driven, consumer-centric care model.
NeueCare细分市场已在佛罗里达州中部扩张,增加了41,000名消费者,并计划在2024年及以后进一步扩张。
2024年第一季度,NeueHealth为NeueCare和NeueSolution领域的共计46.9万名消费者提供了服务。
NeueSolution细分市场内部合作伙伴关系的增长标志着其成为未来的关键驱动力。
该公司为迈阿密戴德市场74.5万名ACA市场消费者中的约40%提供服务,获得了很高的客户满意度分数。
该公司的目标是到2024年底为这两个细分市场的47.5万至50万名消费者提供服务,重点是价值驱动、以消费者为中心的护理模式。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由 AI 生成。无法完全保证内容的准确性。欲了解更多详情,请访问投资者关系网站。本文仅供投资者参考,不构成任何投资建议。